ways in which developing products and technologies are influencing the current standard of patient care. Detailed profiles of the current market leaders and emerging companies are discussed in detail.
Market figures are based on revenues at the manufacturers’ level. The base year for analysis and projection is 2013. Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions and expanded indications for existing products.
This report also includes overviews and forecasts of the separations market by product, by company and by geographic region through 2018. The global market is analyzed, and data are provided for each segment.
When considering flow cytometry values, the numbers cited and projected do not include clinical applications, as clinical applications have been defined as falling outside the biotechnology scope of this report.
Sales figures are reported in U.S. dollars and reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.
All market share data are presented on a global basis unless specifically noted.
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=126733. Alternatively can also get discount on the report @ http://www.reportsnreports.com/contacts/discount.aspx?name=126733.
Major Company Profiles: Affymetrix, Agilent Technologies, Alfa Laval Group, Alfa Wassermann Separation Technologies, Applied Biosystems Corporation and more.
Explore more reports on Biotechnology Market @
Page: 1 2 3 4 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy2
. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response3
. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery4
. ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 20125
. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications6
. Nabsys Expands Leadership Team to Prepare for Commercialization of Novel DNA Positional Sequencing Technology7
. Life Technologies Partners With DaAn Gene to Develop and Commercialize Molecular Diagnostic Assays in China8
. BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board9
. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration10
. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs11
. ERT Launches New Website to Support Significant Commercial Growth